共 14 条
[6]
Long-term health considerations in schizophrenia: Metabolic effects and the role of abdominal adiposity[J] . Luc F. Van Gaal.European Neuropsychopharmacology . 2006
[7]
Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III[J] . Joseph P. McEvoy,Jonathan M. Meyer,Donald C. Goff,Henry A. Nasrallah,Sonia M. Davis,Lisa Sullivan,Herbert Y. Meltzer,John Hsiao,T. Scott Stroup,Jeffrey A. Lieberman.Schizophrenia Research . 2005 (1)
[8]
The metabolic syndrome and schizophrenia: A review[J] . Jonathan Meyer,Carol E. Koro,Gilbert J. L&CloseCurlyQuote,Italien.International Review of Psychiatry . 2005 (3)
[9]
Schizophrenia, the metabolic syndrome and diabetes[J] . R. I. G.Holt,R. C.Peveler,C. D.Byrne.Diabetic Medicine . 2004 (6)
[10]
Serum adiponectin concentrations during treatment with olanzapine or risperidone: a pilot study[J] . Takashi Togo,Katsuo Kojima,Mika Shoji,Akihiko Kase,Hirotake Uchikado,Omi Katsuse,Eizo Iseki,Kenji Kosaka.International Clinical Psychopharmacology . 2004 (1)